News and Trends 2 Dec 2022 Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio …ADHD pipeline products in China. Tris says it has a robust portfolio of FDA-approached products for the treatment of attention deficit/hyperactivity disorder (ADHD) and a pipeline of treatments for pain,… December 2, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2024 Seven biotech companies climbing their way up in Colorado …260 patients with vEDS caused by a COL3A1 mutation. The Colorado-based biotech company also has a portfolio of attention deficit hyperactivity disorder (ADHD) drugs and therapies for allergies in children…. April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jul 2025 Seven biotechs in Belgium making leaps in the clinic …clinical results for atomoxetine, which is a norepinephrine reuptake inhibitor for attention deficit hyperactivity disorder (ADHD). This patent-pending liquid formulation of atomoxetine is designed to offer an alternative to the… July 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jan 2024 Eight mental health biotech companies trying to make a difference to people’s lives …mental health company’s psychiatry pipeline includes investigational therapies for the treatment of generalized anxiety disorder, ADHD, and autism spectrum disorder. In December 2023, MindMed announced positive topline results from its… January 25, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 …a breakthrough in care for attention-deficit/hyperactivity disorder (ADHD), the aforementioned Entresto, and the CDK4/6 inhibitor Kisqali, which has continued to rack up FDA approvals for breast cancer since 2017. It’s also no stranger to controversy; from… October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2018 Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease …the early detection of neurodegenerative diseases easier. The research team and Aura plan to develop the device to be used in other conditions, such as ADHD, autistic spectrum disorders and… June 14, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Expert Advice 12 Sep 2025 Eight biotech career paths where demand is skyrocketing …are made to the manufacturing process. “There’s a growing call for professionals adept at producing pharmaceuticals, particularly those in scarce supply like certain ADHD treatments, GLP-1s, and cell-based therapies,” said… September 12, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Aug 2025 Six psychedelic drug companies aiming to revolutionize mental health treatment Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. In this article, we take a look at six of the top… August 12, 2025 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2022 Trial and new drug for Tourette Syndrome after $250M after funding round completed …number of patients with Tourette Syndrome have co-morbidities like ADHD or OCD. During the phase 2b study they were allowed to continue their medications for those conditions, and their Tourette symptoms measurably… November 3, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email